Eight children have been born in the United Kingdom through a groundbreaking fertility technique that uses the genetic material of three individuals. The aim of the method is to prevent mitochondrial diseases—severe and often fatal conditions passed down from mother to child.
This advanced reproductive technology, developed by scientists in Newcastle, combines genetic material from the biological mother and father with healthy mitochondria from a female donor. Although legal in the UK since 2015, these births mark the first confirmed success stories from the technique.
How It Works
The method involves fertilizing eggs from both the mother and a donor with the father’s sperm in a lab. Before full development, the nuclear DNA—responsible for inherited traits such as eye color and height—is removed from both embryos. The parents’ DNA is then inserted into the donor’s embryo, which contains healthy mitochondria. The result is a child who is genetically the parents’ but with a tiny percentage (around 0.1%) of DNA from the donor, specifically from the mitochondria.
Life-Changing Results
The babies were born without signs of mitochondrial disease and are developing normally, according to doctors at the Newcastle Fertility Centre, where the procedures were carried out. The families, while choosing to remain anonymous, expressed deep gratitude.
One mother said the treatment brought them hope after years of uncertainty, while another called it a life-changing development that had lifted the emotional weight of genetic disease.
Ongoing Monitoring and Concerns
Though most babies showed no traces of defective mitochondria, a few had low levels—ranging from 5% to 20%—which remain below the threshold typically associated with disease. Medical experts say more long-term research is needed to understand and minimize such risks.
A small number of health issues, such as epilepsy and abnormal heart rhythms, have occurred, though these are not believed to be directly linked to the technique.
Broader Impact
Around one in 5,000 babies is born with mitochondrial disease, which can lead to muscle weakness, seizures, organ failure, and even death in infancy. Since mitochondria are only passed through the maternal line, the technique offers at-risk families the chance to have healthy children.
With ongoing demand, around 20 to 30 children could be born each year using this method in the UK alone.
A Global First
The UK is the only country so far to both develop the science and pass legislation permitting the creation of babies using mitochondrial donation. Although the procedure has sparked ethical debate—due to the permanent change in a child’s genetic lineage—it has been hailed as a landmark in preventing inherited disease.
Professor Doug Turnbull of Newcastle University praised the achievement, noting that the success was made possible by a combination of scientific excellence, supportive legislation, and NHS infrastructure.
Liz Curtis, founder of the Lily Foundation, a charity supporting families affected by mitochondrial disease, described the births as “the first real hope” for breaking the cycle of inheritance for affected families.
